News & Events
News & Events

News Releases

January 10, 2017

Profil Institute for Clinical Research, Inc. Announces Corporate Name Change to ProSciento, Inc. to Reflect Expanded Metabolism-Focused Clinical R&D Services Read More »

September 14, 2016

Profil Institute for Clinical Research, Inc. and Antaros Medical Form Strategic Alliance to Incorporate Advanced Functional Imaging Techniques into Cardiometabolic Clinical Research Read More »

July 28, 2016

Profil Institute and HighTide Biopharmaceutical Announce a Strategic Partnership Focused on the Development of New Therapies for Diabetes and NAFLD/NASH Read More »

June 10, 2016

Profil Institute and LMC Diabetes Launch Strategic Partnership to Conduct Cross-Border Multi-Site Trials in Diabetes and Metabolism Read More »

June 9, 2016

 Profil Institute and mySugr Collaborate to Advance Evidence-Based Clinical Validation of Diabetes mHealth Solutions Read More »

June 6, 2016

Profil Institute Presents at the American Diabetes Association’s 76th Annual Scientific Sessions in New Orleans Read More »

April 5, 2016

Profil Institute Assembles Team of 92 and Raises More Than $27,000 for American Diabetes Association’s Tour de Cure in San Diego Read More »

December 1, 2015

Profil Institute Appoints Dr. Christian Weyer as President and Chief Development Officer Read More »

November 24, 2015

Profil Institute Appoints Meryl Wiernik as Senior Director of CRO Services Read More »

November 9, 2015

Congratulations to Hanmi Pharmaceutical Co., Ltd. Read More »

October 29, 2015

Profil Institute’s Corporate Team is Proud to Celebrate Its 11th Year Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego Read More »

October 28, 2015

Profil Institute and KineMed Collaborate to Pursue Circulating Biomarkers for NAFLD/NASH Clinical Research Read More »

October 28, 2015

Profil Institute Announces Collaboration with Leading NAFLD/NASH Expert Dr. Rohit Loomba Read More »

October 28, 2015

Profil Institute Unites Leading Experts in Biomarker Discovery and Clinical Research to Address the Medical Challenges of NAFLD/NASH Read More »

October 13, 2015

Profil Institute Prepares to ‘Step Out’ Against Diabetes for an 11th Year, While Raising More Than $40,000 for the American Diabetes Association This Year Read More »

October 8, 2015

Profil Institute Publishes White Paper Series Focused on the Current State of Diabetes, Obesity and NAFLD/NASH Clinical Research and Development Read More »

September 10, 2015

Profil Institute Presents Diabetes, Obesity and NASH Research Study Results at the European Association for the Study of Diabetes Annual Meeting Read More »

June 4, 2015

Profil Institute Announces Metabolism Focused ‘Discover & Translate’ Partnership with Gubra Read More »

May 30, 2015

Profil Institute Presents at the American Diabetes Association’s 75th Annual Scientific Sessions in Boston Read More »

May 7, 2015

Profil Institute Expands Clinical Development Leadership Team With Prominent Industry Experts Drs. Michael Trautmann and Gordon Brandt Read More »

April 15, 2015

Profil Institute Assembles Team of 70 and Raises $35,000 for American Diabetes Association’s Tour de Cure in San Diego Read More »

January 22, 2015

New Textbook “Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development” Provides Critical Review of Current and Emerging Clinical Investigation Methods Read More »

November 18, 2014

Profil Institute to Present at the Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Read More »

October 27, 2014

Profil Institute’s Corporate Team is Proud to Celebrate a Decade of Walking and Sponsoring JDRF’s ‘Walk to Cure Diabetes’ Event in San Diego Read More »

October 24, 2014

Profil Institute Teams Up With American Diabetes Association to ‘Step Out’ Against Diabetes and Celebrates Its Tenth Year as a Corporate Sponsor Read More »

October 11, 2014

Profil Institute Continues to Publish New Findings in Cardiometabolic Research Read More »

September 2, 2014

Profil Institute to Present Key Diabetes and Insulin Research at the 50th European Association for the Study of Diabetes Annual Meeting Read More »

August 26, 2014

Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes Read More »

June 19, 2014

Profil Institute’s CEO Dr. Marcus Hompesch to Present at the Best of ADA Middle East Conference in Dubai Read More »

June 9, 2014

Profil Institute to Present at the American Diabetes Association’s 74th Annual Scientific Sessions in San Francisco Read More »

April 23, 2014

Profil Institute Celebrates its 10th year as a Corporate Sponsor and Team of Cyclists Fundraising for American Diabetes Association’s Tour de Cure in San Diego Read More »

April 15, 2014

Profil Institute Executives Presenting on Early Phase Clinical Research in India, China and Japan Read More »

February 12, 2014

DiaVacs Announces a Strategic Collaboration with Profil Institute to Conduct Phase IB/IIA Randomized Clinical Trial of New Cell-Based Therapy for Type 1 Diabetes Read More »

January 31, 2014

Profil Institute Celebrates 10 Years of Outstanding Science, Clinical Research, and Commitment to the Diabetes and Obesity Patient Community Read More »

November 4, 2013

Profil Institute Appoints Dan Bradbury, former Amylin Pharmaceutical CEO, to Board of Directors Read More »

October 22, 2013

Profil Institute Teams Up With American Diabetes Association to ‘Step Out’ Against Diabetes Read More »

September 20, 2013

Profil Institute to Present Key Diabetes and Insulin Research at the 49th European Association for the Study of Diabetes Annual Meeting Read More »

September 5, 2013

Profil Institute’s Recruitment Manager is Recipient of Insulindependence IN Champion Award Read More »

July 3, 2013

Profil Institute Decides to Not Pursue Formal Joint Venture with Florida Hospital, But Will Continue to Work Collaboratively Read More »

June 4, 2013

Profil Institute’s Sr. Scientific Director Publishes Textbook on New and Emerging Therapeutics for Type 2 Diabetes Read More »

April 17, 2013

Profil Institute Assembles Team of 80 Cyclists for American Diabetes Association’s Tour de Cure in San Diego Read More »

April 10, 2013

Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials Read More »